An unusual orbital presentation of COVID-19-associated mucormycosis

Abstract

Coronavirus disease 2019 (COVID-19) is an ongoing pandemic that spreads mainly through close contact and tiny respiratory droplets. The ocular surface is a potential site for transmission, whereas the ophthalmologists are highly potential to acquire infection. Because of the presence of the angiotensin enzyme 2 in different ocular tissues and cytokine storm results in vasoconstriction, ischemia, hypercoagulopathy, and thromboembolic phenomenon, this virus easily binds and in different ocular manifestations such as conjunctivitis, retinal vascular occlusion, diabetes retinopathy, ocular nerve palsies, and orbital mucormycosis. Mucormycosis is a life-threatening infection that often affects patients with diabetes mellitus and other immunocompromised patients. The diagnosis of mucormycosis is usually done by microbiological tests and radiological investigations. Proper ocular care and awareness among clinicians need the hour for prompt management of orbital mucormycosis. Here, we are presenting a case of COVID-19-associated mucormycosis with subconjunctival involvement of mucormycosis.